Search

Your search keyword '"C. Sefonte"' showing total 2 results
Start Over Author "C. Sefonte"
2 results on '"C. Sefonte"'

1. Monitoring and treatment of anti-D in pregnancy

Author

S. Villa, Frank P.H.A. Vandenbussche, Ulrik Sprogøe, H. H. H. Kanhai, D. Gounder, B. Csapo, C. Pessoa, W. Stein, C. Sefonte, Simon Panzer, Ansa Aitokallio-Tallberg, D. Bettelheim, Tobias J. Legler, Svein Magne Skulstad, Malla Kuosmanen, Peter Flanagan, S. Koskinen, Maria Antonietta Villa, F. Guerra, L. Trespidi, Emma Parry, B. Zupanska, Olav Lapaire, Xiao Yan Zhong, Morten Hanefeld Dziegiel, Wolfgang Holzgreve, Tor Hervig, M. de Haas, Małgorzata Uhrynowska, B. Acaia, Henk W. Reesink, S. Wendel, Anneke Brand, R. Donegan, Pavel Calda, O Flesland, Gastroenterology and Hepatology, and Landsteiner Laboratory

Subjects
medicine.medical_specialty, Pediatrics, Rho(D) Immune Globulin, 030204 cardiovascular system & hematology, Rh Isoimmunization, Blood group antigens, 03 medical and health sciences, 0302 clinical medicine, Isoantibodies, Pregnancy, Medicine, Humans, Intensive care medicine, Fetal Hemoglobin, 030219 obstetrics & reproductive medicine, Rh-Hr Blood-Group System, Cardiovascular diseases [NCEBP 14], business.industry, Incidence (epidemiology), Public health, Pregnancy Complications, Hematologic, Hematology, General Medicine, medicine.disease, Fetal Blood, 3. Good health, Immunization, Blood Group Antigens, Treatment strategy, Female, business, Haemolytic disease
Abstract

Prophylactic anti-D is a very safe and effective therapy for the suppression of anti-D immunization and thus prevention of haemolytic disease of the foetus and newborn. However, migration from countries with low health standards and substantial cuts in public health expenses have increased the incidence of anti-D immunization in many "developed" countries. Therefore, this forum focuses on prenatal monitoring standards and treatment strategies in pregnancies with anti-D alloimmunization. The following questions were addressed, and a response was obtained from 12 centres, mainly from Europe.

Published
2010
Full Text
View/download PDF

2. Monitoring and treatment of anti-D in pregnancy.

Author

Bettelheim D, Panzer S, Reesink HW, Csapo B, Pessoa C, Guerra F, Wendel S, Calda P, Sprogøe U, Dziegiel M, Aitokallio-Tallberg A, Koskinen S, Kuosmanen M, Legler TJ, Stein W, Villa S, Villa MA, Trespidi L, Acaia B, Vandenbussche FP, Brand A, de Haas M, Kanhai HH, Gounder D, Flanagan P, Donegan R, Parry E, Sefonte C, Skulstad SM, Hervig T, Flesland Ø, Zupańska B, Uhrynowska M, Lapaire O, Zhong XY, and Holzgreve W

Subjects
Female, Fetal Blood immunology, Fetal Hemoglobin analysis, Humans, Isoantibodies blood, Isoantibodies immunology, Pregnancy, Pregnancy Complications, Hematologic blood, Pregnancy Complications, Hematologic immunology, Pregnancy Complications, Hematologic prevention & control, Rh Isoimmunization immunology, Rh Isoimmunization prevention & control, Rho(D) Immune Globulin, Blood Group Antigens immunology, Isoantibodies administration & dosage, Pregnancy Complications, Hematologic therapy, Rh Isoimmunization therapy, Rh-Hr Blood-Group System immunology
Abstract

Prophylactic anti-D is a very safe and effective therapy for the suppression of anti-D immunization and thus prevention of haemolytic disease of the foetus and newborn. However, migration from countries with low health standards and substantial cuts in public health expenses have increased the incidence of anti-D immunization in many "developed" countries. Therefore, this forum focuses on prenatal monitoring standards and treatment strategies in pregnancies with anti-D alloimmunization. The following questions were addressed, and a response was obtained from 12 centres, mainly from Europe.

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results